Frank Herringer

Track

Insider profile

Currently holds a position at Charles Schwab Corp

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
11 64% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Charles Schwab Corp Jan. 1, 1996 -
Director Amgen Inc Jan. 1, 2017 - May 21, 2019
Independent Director Amgen Inc May 1, 2004 - Jan. 1, 2017
Independent Director Safeway Inc March 6, 2008 - Jan. 30, 2015
Frank Herringer's trades of Charles Schwab Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
488.42
Quantity 87,993 -31.6%
Value US$1,483,087
Transaction date
Proposed sale
Price
399.35
Quantity 84,320
Value US$4,583,994
Transaction date
Sale
Price
192.23
Quantity 55,943 -21.2%
Value US$715,807
Transaction date
Proposed sale
Price
74.26
Quantity 3,592
Value US$266,731
Transaction date
Proposed sale
Price
62.25
Quantity 7,587
Value US$472,277
Transaction date
Sale
Price
80.87
Quantity 9,139 -5.5%
Value US$739,051
Transaction date
Proposed sale
Price
80.87
Quantity 9,139
Value US$739,050
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.77
Quantity 500 +inf%
Value US$28,384
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.77
Quantity 500 +inf%
Value US$28,384
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.90
Quantity 500 +7.7%
Value US$28,450
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.89
Quantity 300 +4.8%
Value US$17,067
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.91
Quantity 1,200 +24.0%
Value US$68,290
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.93
Quantity 1,400 +233.3%
Value US$79,702
US Amgen Inc (AMGN)
Transaction date
Purchase
Price
56.94
Quantity 600 +inf%
Value US$34,164
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-29 2026-04-28
S Sale
87,993 -31.6%
488.42
US$1,483,087 		87,993 -31.6% 488.42 US$1,483,087
2026-04-28 2026-04-28
PrS Proposed sale
84,320
399.35
US$4,583,994 		84,320 399.35 US$4,583,994
2025-04-22 2025-04-21
S Sale
55,943 -21.2%
192.23
US$715,807 		55,943 -21.2% 192.23 US$715,807
2025-04-21 2025-04-21
PrS Proposed sale
3,592
74.26
US$266,731 		3,592 74.26 US$266,731
2024-02-05 2024-02-01
S Sale
7,587 -4.3%
62.25
US$472,277 		7,587 -4.3% 62.25 US$472,277
2024-02-01 2024-02-01
PrS Proposed sale
7,587
62.25
US$472,277 		7,587 62.25 US$472,277
2023-02-16 2023-02-14
S Sale
9,139 -5.5%
80.87
US$739,051 		9,139 -5.5% 80.87 US$739,051
2023-02-14 2023-02-14
PrS Proposed sale
9,139
80.87
US$739,050 		9,139 80.87 US$739,050
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
500 +inf%
56.77
US$28,384 		500 +inf% 56.77 US$28,384
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
500 +inf%
56.77
US$28,384 		500 +inf% 56.77 US$28,384
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
500 +7.7%
56.90
US$28,450 		500 +7.7% 56.90 US$28,450
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
300 +4.8%
56.89
US$17,067 		300 +4.8% 56.89 US$17,067
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
1,200 +24.0%
56.91
US$68,290 		1,200 +24.0% 56.91 US$68,290
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
1,400 +233.3%
56.93
US$79,702 		1,400 +233.3% 56.93 US$79,702
2004-05-17 2004-05-14
US Amgen Inc (AMGN)
B Purchase
600 +inf%
56.94
US$34,164 		600 +inf% 56.94 US$34,164